CAS RN: 2092522-63-7
6-Bromo-3-(difluoromethyl)imidazo[1,2-a]pyridine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250205
100mg / 250mg / 1g
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2092522-63-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Shenzhen
Inquiry
2092522-63-7 / 6-bromo-3-(difluoromethyl)imidazo[1,2-a]pyridine
Standard CAS: 2092522-63-7
Multi CAS: No
Basic Information
copy
CAS
2092522-63-7 copy
Multi CAS
No copy
Molecular Formula
C8H5BrF2N2 copy
Molecular Weight
247.040000 copy
Exact Mass
245.960420 copy
SMILES
C1=CC2=NC=C(N2C=C1Br)C(F)F copy
InChI
InChI=1S/C8H5BrF2N2/c9-5-1-2-7-12-3-6(8(10)11)13(7)4-5/h1-4,8H copy
InChIKey
BSPGPKZDETZQMM-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
13 copy
Aromatic heavy atom count
9 copy
Fraction Csp3
0.12 copy
Rotatable bonds
1 copy
H-bond acceptors
2 copy
Molar refractivity
47.85 copy
TPSA
17.3 copy
LogP / Solubility
WLOGP
3.03 copy
MLOGP
2.68 copy
XLogP3
3.1 copy
Consensus LogP
2.94 copy
Log S (ESOL)
-3.73 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.78 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.9 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.07 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy